TRSSX
Price
$26.93
Change
+$0.02 (+0.07%)
Updated
Jun 2 closing price
Net Assets
4.64B
VISGX
Price
$100.64
Change
+$0.72 (+0.72%)
Updated
Jun 2 closing price
Net Assets
42.8B
Interact to see
Advertisement

TRSSX vs VISGX

Header iconTRSSX vs VISGX Comparison
Open Charts TRSSX vs VISGXBanner chart's image
TRSSX vs VISGX Comparison Chart in %
View a ticker or compare two or three
VS
TRSSX vs. VISGX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRSSX is a Buy and VISGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VISGX has more cash in the bank: 42.8B vs. TRSSX (4.64B). VISGX pays higher dividends than TRSSX: VISGX (0.34) vs TRSSX (0.28). TRSSX was incepted earlier than VISGX: TRSSX (26 years) vs VISGX (28 years). TRSSX (0.66) is less costly to investors than VISGX (0.19). TRSSX is a more actively managed with annual turnover of: 84.10 vs. VISGX (24.00). VISGX has a lower initial minimum investment than TRSSX: VISGX (0) vs TRSSX (1000000). VISGX annual gain was more profitable for investors over the last year : 34.40 vs. TRSSX (11.82). VISGX return over 5 years is better than : 30.62 vs. TRSSX (-19.37).
TRSSXVISGXTRSSX / VISGX
Total Expense Ratio0.660.19347%
Annual Report Gross Expense Ratio0.660.19347%
Fund Existence26 years28 years-
Gain YTD10.37717.75958%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.64B42.8B11%
Annual Yield % from dividends0.280.3482%
Returns for 1 year11.8234.4034%
Returns for 3 years9.0261.4415%
Returns for 5 years-19.3730.62-63%
Returns for 10 years41.77190.0622%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FEBO0.860.02
+2.96%
Fenbo Holdings Limited
BAP343.933.37
+0.99%
Credicorp Ltd
MMSI60.89-1.16
-1.87%
Merit Medical Systems
OWLT5.25-0.24
-4.37%
Owlet
ETON27.34-1.34
-4.67%
Eton Pharmaceuticals